Sign inJoin waitlistJoin the waitlist

Noa Biran

Physician · Regional Cancer Care Associates LLC

Credentials: · · · · ·

History

Regional Cancer Care Associates LLC
Present

Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
2011–2014
Internal Medicine
2008–2011
George Washington Univ Sch of Med
2004–2008

Research

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
The Lancet Rheumatology · 2020 · First of 29 authors · 207 citations
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Blood · 2020 · 167 citations
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
PLoS ONE · 2020 · 98 citations

David Siegel
42 papers
David Vesole
35 papers
Harsh Parmar
19 papers
Pooja Phull
17 papers · 1 as a fellow
Ajai Chari
14 papers
Joshua Richter
13 papers
Andrew Pecora
10 papers
Michele Donato
8 papers
Sundar Jagannath
8 papers
Andrew Ip
7 papers · 3 as a fellow
Eli Zolotov
7 papers · 7 as a resident
Natalie Callander
7 papers

Clinical trials

Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.
Principal investigator · Withdrawn · Phase 1, Phase 2
Hackensack Meridian Health
2022–2025
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
Principal investigator · Suspended · Phase 1, Phase 2
Hackensack Meridian Health
2022–2027
A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma
Principal investigator · Terminated · Phase 2
Hackensack Meridian Health
2022–2023
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Principal investigator · Recruiting · Phase 2
Hackensack Meridian Health
2021–2028